R. Mroz (Bialystok, Poland), B. Schmidt (Halle, Germany)
An evaluation of the potential for inhaled xenobiotics to develop cancer in the lung using a 3D in vitro model of the human epithelial airway-wall M. Clift, D. Studer, P. Wick, T. Geiser, P. Gehr, R. Schins, B. Rothen-Rutishauser (Bern, St. Gallen, Switzerland; Duesseldorf, Germany)
| |
Nitrosoglutathione reductase inhibition in the airway epithelium may contribute to lung cancer risk N. Marozkina, D. Jones, S. Yemen, B. Gaston (Charlottesville, United States Of America)
| |
COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia A. Mohamed, K. Shibuya, I. Yoshino, T. Mahfouz, A. Abdrabou, M. Elkholy (Assuit, Egypt; Chiba, Japan)
| |
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD C. Fermoselle, V. Curull, A. Sanchez-Font, L. Pijuan, J. Gea, E. Barreiro (Barcelona, Spain)
| |
Detection of patients with lung cancer out of a risk group by breath sample presentation to sniffer dogs R. Ehmann, E. Boedeker, U. Friedrich, J. Sagert, T. Walles, G. Friedel (Stuttgart, Gerlingen, Löffingen, Germany)
| |
A new possibility of process monitoring in lung cancer: Volatile organic compounds detected with ion mobility spectrometry to follow the success of the therapeutic process J. I. Kurth, K. Darwiche, J. I. Baumbach, L. Freitag (Essen, Saarbruecken, Germany)
| |
Volatile organic compounds in lung cancer patients before and after tumour resection K. Darwiche, I. Kurth, J. I. Baumbach, U. Sommerwerck, H. Teschler, L. Freitag (Essen, Saarbruecken, Germany)
| |
New contributions in the determination of volatile organic compounds (VOC) in lung cancer (LC) J. Jareño, M. A. Muñoz, G. Rodríguez, C. Civera, A. Aguilar, J. A. Maldonado, B. Carrillo, C. Gutiérrez, M. V. García, B. Morales, J. L. Álvarez-Sala, L. Callol (Madrid, Boadilla del Monte, Spain)
| |
Discriminating NSCLC from COPD using patterns derived from an electronic nose C. Molik-Oeser, S. Tahanovich, O. Schroeder, S. Hammerschmidt, R. Genzel, M. Syhre, H. Wirtz (Leipzig, Borsdorf, Germany)
| |
Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease N. Vaguliene, S. Lavinskiene, M. Zemaitis, S. Miliauskas, R. Sakalauskas (Kaunas, Lithuania)
| |
The eosinophilic infiltration of lung cancer tissue and its relationship with the expression of IL-5 B. He, X. Han (Beijing, China)
| |
Association of genetic polymorphisms of matrix metalloproteinase (MMP)14 to the susceptibility of non-small cell lung cancer Y. L. Lee, W. E. Cheng, S. C. Chen, C. M. Shih, W. Chen (Taichung, Chia-Yi, Taiwan)
| |
The expression and clinical significance of PD-L1+CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer J. A. Huang, Y. B. Chen, P. Xu (Suzhou, China)
| |
Circulating CD133(+) stem cells in lung cancer patients J. Domagala-Kulawik, T. Skirecki, G. Hoser (Warsaw, Poland)
| |
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) M. Petrovic, N. Ilic, Z. Lazic, I. Cekerevac, L. Novkovic, G. Kostic, V. Cupurdija (Kragujevac, Republic Of Serbia)
| |
Magnolol can induce apoptosis in non-small cell lung cancer via caspase-independent pathway S. H. Chu, P. L. Liu, J. R. Tsai, I. W. Chong (Kaohsiung, Taiwan)
| |
Emerging prognostic biomarkers in non small cell lung cancer patients: Impact of treatment with nimesulide (COX-2 inhibitor) combined with chemotherapy S. Abdel-Ghany, N. Elmelegy, A. Mohamed-Hussein, R. Hana (Assiut, Egypt)
| |
Investigation of biomarkers for pulmonary carcinomatous lymphangitis in patients with lung cancer M. Kawaishi, M. Hashimoto, H. Yanagisawa, T. Kazuyori, N. Takasaka, Y. Yumino, S. Fujii, J. Kojima, T. Ishikawa, T. Numata, H. Hara, K. Saito, J. Araya, K. Nakayama, K. Kuwano (Tokyo, Japan)
| |
Microparticle-associated tissue factor activity is increased in late stage lung cancer F. Martino, M. Zurlo, T. Neri, S. Cini, A. Chella, A. Palla, E. Mariancini, A. Celi, L. M. Tavanti (Pisa, Italy)
| |